Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Pharmaceutics|June 27, 2024
Archaeosomes for Oral Drug Delivery: From Continuous Microfluidics Production to Powdered FormulationsIvan Vidakovic, Karin Kornmueller, Daniela Fiedler, et al.International Journal of Nanomedicine|September 13, 2014
Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesionsGunter Almer, Kelli L Summers, Bernhard Scheicher, et al.International Journal of Nanomedicine|December 11, 2012
Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticlesChristine Rangger, Anna Helbok, Elisabeth von Guggenberg, et al.International Journal of Nanomedicine|December 20, 2013
Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticlesChristine Rangger, Anna Helbok, Jane Sosabowski, et al.Nano Research|August 21, 2015
Tracking morphologies at the nanoscale: self-assembly of an amphiphilic designer peptide into a double helix superstructureKarin Kornmueller, Ilse Letofsky-Papst, Kerstin Gradauer, et al.Current Pharmaceutical Biotechnology|April 8, 2011
Combined light and electron microscopy using diaminobenzidine photooxidation to monitor trafficking of lipids derived from lipoprotein particlesClemens Röhrl, Claudia Meisslitzer-Ruppitsch, Robert Bittman, et al.Molecular Pharmaceutics|November 27, 2012
Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomesGunter Almer, Daniela Frascione, Isabella Pali-Schöll, et al.Obesity (Silver Spring, Md.)|April 30, 2013
Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndromeHarald Mangge, Kelli L Summers, Andreas Meinitzer, et al.Life Sciences|June 5, 2020
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancementsAbhjieet Pandey, Ajinkya Nitin Nikam, Ajjappla Basavaraj Shreya, et al.Pharmaceutics|July 29, 2023
Lipid Nanoparticles as a Shuttle for Anti-Adipogenic miRNAs to Human AdipocytesAnna-Laurence Schachner-Nedherer, Julia Fuchs, Ivan Vidakovic, et al.Pageof 7